AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32462947 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDCS stimulation over the left M1
Number of subjects: 28
Study 32462947 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDCS stimulation over the PPC
Number of subjects: 28
Study 32653025 — intervention group
Group type: EXPERIMENTAL
Intervention: KAIA COPD app program
Number of subjects: 104
Study 32653025 — intervention group
Group type: COMPARATOR
Intervention: Usual care (active comparator)
Number of subjects: 104
Study 36114799 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine 40-mg
Number of subjects: 256
Study 36114799 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine 80-mg
Number of subjects: 256
Study 36114799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 36114799 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine (after switching from placebo at Week 6)
Number of subjects: 256
Study 36114799 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine 40-mg and 80-mg
Number of subjects: 256
Study 33653802 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin 0.5 mg
Number of subjects: 31
Study 33653802 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin 2.0 mg
Number of subjects: 31
Study 33653802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 36145067 — intervention group
Group type: EXPERIMENTAL
Intervention: LCHF diet (<50 g CHO p/day)
Number of subjects: 16
Study 36145067 — intervention group
Group type: COMPARATOR
Intervention: HCLF diet
Number of subjects: 16
Study 36145067 — intervention group
Group type: EXPERIMENTAL
Intervention: LCHF diet
Number of subjects: 16
Study 34560444 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurement per routine intraoperatively, and with continuous non‐invasive monitoring postoperatively
Number of subjects: 550
Study 34560444 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative hypotension
Number of subjects: 550
Study 615901264 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel (1.25 g, 2.5 g, 5.0 g, 10 g, or 15 g)
Number of subjects: 48
Study 615901264 — intervention group
Group type: COMPARATOR
Intervention: Double placebo (injections and gel)
Number of subjects: 48
Study 34238815 — intervention group
Group type: EXPERIMENTAL
Intervention: IDEAL 2b study
Number of subjects: 0
Study 34238815 — intervention group
Group type: EXPERIMENTAL
Intervention: Other methods (observational study designs, registry-based approaches)
Number of subjects: 0
Study 32342885 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosives detection systems for cabin baggage screening (EDSCB) with varying automation reliability measures (accuracy, d', PPV)
Number of subjects: 122
Study 32342885 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosives detection systems for cabin baggage screening (EDSCB) with higher d'
Number of subjects: 122
Study 32342885 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosives detection systems for cabin baggage screening (EDSCB) with a high false alarm rate of 20% and a low PPV of .3
Number of subjects: 122
Study 32342885 — intervention group
Group type: EXPERIMENTAL
Intervention: Automation reliability described by d' and PPV
Number of subjects: 122
Study 32342885 — intervention group
Group type: EXPERIMENTAL
Intervention: Automation with PPV below .5
Number of subjects: 122
Study 36484186 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaohe Yinyang acupotomy
Number of subjects: 88
Study 36484186 — intervention group
Group type: COMPARATOR
Intervention: Sham‐acupotomy
Number of subjects: 88
Study 34385364 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL200 + MTX
Number of subjects: 510
Study 34385364 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL100 + MTX
Number of subjects: 510
Study 34385364 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL200
Number of subjects: 510
Study 34385364 — intervention group
Group type: COMPARATOR
Intervention: MTX-mono
Number of subjects: 510
Study 32595022 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen-section examination (FSE) of sentinel lymph nodes (SLN)
Number of subjects: 313
Study 32595022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrastaging of negative SLNs by FSE
Number of subjects: 313
Study 32595022 — intervention group
Group type: COMPARATOR
Intervention: Tumor size ≥ 20 mm
Number of subjects: 313
Study 32595022 — intervention group
Group type: COMPARATOR
Intervention: Preoperative brachytherapy
Number of subjects: 313
Study 32595022 — intervention group
Group type: COMPARATOR
Intervention: Higher volume center (>5 patients/year)
Number of subjects: 313
Study 34597384 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (antioxidant)
Number of subjects: 58
Study 34597384 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 58
Study 33723119 — intervention group
Group type: EXPERIMENTAL
Intervention: Hall Technique (HT)
Number of subjects: 35
Study 33723119 — intervention group
Group type: COMPARATOR
Intervention: Conventional Restoration (CR)
Number of subjects: 35
Study 33723119 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HT and CR
Number of subjects: 35
Study 32335270 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric ethanol infusion (IGEI)
Number of subjects: 12
Study 32335270 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ethanol infusion (IVEI)
Number of subjects: 12
Study 32335270 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IGEI and IVEI
Number of subjects: 12
Study 35025163 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion
Number of subjects: 0
Study 35025163 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36309846 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental vitamin A (10,000 IU/day orally for 3 to 4 weeks)
Number of subjects: 47
Study 36309846 — intervention group
Group type: COMPARATOR
Intervention: No supplemental vitamin A (control)
Number of subjects: 47
Study 33561277 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp Acupuncture (SA)
Number of subjects: 60
Study 33561277 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal Splint (OS)
Number of subjects: 60
Study 33561277 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 60
Study 33561277 — intervention group
Group type: COMPARATOR
Intervention: Counseling (C)
Number of subjects: 60
Study 32207158 — intervention group
Group type: EXPERIMENTAL
Intervention: Portion-control intervention (PCI) group received weekly, telephone-delivered behavioral counseling over 12 weeks.
Number of subjects: 0
Study 32207158 — intervention group
Group type: COMPARATOR
Intervention: Newsletter group received monthly newsletters regarding healthy eating.
Number of subjects: 0
Study 35316099 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adjusted hearing aid amplification
Number of subjects: 15
Study 35316099 — intervention group
Group type: COMPARATOR
Intervention: NAL-NL2 prescriptive fit
Number of subjects: 15
Study 35316099 — intervention group
Group type: COMPARATOR
Intervention: Experimenter-created fits with reduced gain
Number of subjects: 15
Study 34828764 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 60
Study 34828764 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 60
Study 34828764 — intervention group
Group type: COMPARATOR
Intervention: Control group (no local anesthetic)
Number of subjects: 60
Study 32940653 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol thermosensitive gel (0.1%) applied twice daily for 8 weeks
Number of subjects: 27
Study 32940653 — intervention group
Group type: COMPARATOR
Intervention: Placebo thermosensitive gel applied twice daily for 8 weeks
Number of subjects: 27
Study 32940653 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol thermosensitive gel (0.1%)
Number of subjects: 27
Study 32940653 — intervention group
Group type: COMPARATOR
Intervention: Placebo thermosensitive gel
Number of subjects: 27
Study 33879185 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbidity burden
Number of subjects: 520
Study 33879185 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated health (not good vs. good)
Number of subjects: 520
Study 33879185 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health wellbeing
Number of subjects: 520
Study 33879185 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of offspring (among Jewish participants)
Number of subjects: 520
Study 33879185 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived difficulty (among Jewish participants)
Number of subjects: 520
Study 33879185 — intervention group
Group type: COMPARATOR
Intervention: Sociodemographics, health behaviors, knowledge and attitudes/beliefs
Number of subjects: 520
Study 35766991 — intervention group
Group type: EXPERIMENTAL
Intervention: One-on-one 30- to 45-min psychosocial counseling session with a psychosexual counselor plus written educational materials
Number of subjects: 31
Study 32363940 — intervention group
Group type: EXPERIMENTAL
Intervention: IMMAX® + nutritional counseling (NC) for 4 weeks
Number of subjects: 85
Study 32363940 — intervention group
Group type: COMPARATOR
Intervention: Nutritional counseling (NC) alone for 4 weeks
Number of subjects: 85
Study 32663518 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo confocal microscopy (IVCM) for NCP patients
Number of subjects: 71
Study 32663518 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo confocal microscopy (IVCM) for DED patients
Number of subjects: 71
Study 32663518 — intervention group
Group type: COMPARATOR
Intervention: In vivo confocal microscopy (IVCM) for NCP and DED patients
Number of subjects: 71
Study 35303782 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib plus endocrine therapy
Number of subjects: 0
Study 35303782 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib and fulvestrant
Number of subjects: 0
Study 35303782 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 0
Study 32398199 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-dose rifampicin (20 mg/kg/d)
Number of subjects: 690
Study 32398199 — intervention group
Group type: COMPARATOR
Intervention: Standard dose rifampicin (10 mg/kg/d)
Number of subjects: 690
Study 36055669 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TXA 2 g
Number of subjects: 452
Study 36055669 — intervention group
Group type: EXPERIMENTAL
Intervention: IV TXA 2 g
Number of subjects: 452
Study 36055669 — intervention group
Group type: COMPARATOR
Intervention: NO TXA (Control)
Number of subjects: 452
Study 32746647 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide (LAN) and antidiarrhoeal treatments (TAD)
Number of subjects: 15
Study 32746647 — intervention group
Group type: COMPARATOR
Intervention: Antidiarrhoeal treatments only (TADS)
Number of subjects: 15
Study 36062951 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILS)
Number of subjects: 2931
Study 36062951 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2931
Study 36062951 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 2931
Study 33464934 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured communication rehabilitation programme (EG)
Number of subjects: 12
Study 33464934 — intervention group
Group type: COMPARATOR
Intervention: Communication group based on free conversation (CG)
Number of subjects: 12
Study 33166718 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg fixed dose)
Number of subjects: 1512
Study 33166718 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2)
Number of subjects: 1512
Study 33166718 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1512
Study 33166718 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 1512
Study 32472012 — intervention group
Group type: EXPERIMENTAL
Intervention: NOMAC/E2 (2.5 mg nomegestrol acetate and 1.5 mg estradiol)
Number of subjects: 69
Study 32472012 — intervention group
Group type: COMPARATOR
Intervention: GS/EE (0.075 mg gestodene and 0.02 mg ethinyl estradiol)
Number of subjects: 69
Study 32472012 — intervention group
Group type: EXPERIMENTAL
Intervention: NOMAC/E2
Number of subjects: 69
Study 32472012 — intervention group
Group type: COMPARATOR
Intervention: GS/EE
Number of subjects: 69
Study 34543276 — intervention group
Group type: EXPERIMENTAL
Intervention: High urinary volume (HV)
Number of subjects: 155
Study 34543276 — intervention group
Group type: COMPARATOR
Intervention: Low urinary volume (LV)
Number of subjects: 155
Study 34543276 — intervention group
Group type: EXPERIMENTAL
Intervention: Voiding status (VC)
Number of subjects: 155
Study 34543276 — intervention group
Group type: COMPARATOR
Intervention: Not able to void (NVC)
Number of subjects: 155
Study 32279690 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant starch (RS) supplementation for 50 days
Number of subjects: 75
Study 32279690 — intervention group
Group type: COMPARATOR
Intervention: Polydextrose (PD) supplementation for 50 days
Number of subjects: 75
Study 32279690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 35772671 — intervention group
Group type: EXPERIMENTAL
Intervention: Active DBS
Number of subjects: 25
Study 35772671 — intervention group
Group type: COMPARATOR
Intervention: Sham DBS
Number of subjects: 25
Study 33789683 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT-style VPA intervention (additional 10 min of VPA per PE lesson for one academic year)
Number of subjects: 18261
Study 33789683 — intervention group
Group type: COMPARATOR
Intervention: PE as usual (control condition)
Number of subjects: 18261
Study 32766808 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Medicine (OMM)
Number of subjects: 30
Study 32766808 — intervention group
Group type: COMPARATOR
Intervention: Concussion Education
Number of subjects: 30
Study 35134970 — intervention group
Group type: EXPERIMENTAL
Intervention: Anifrolumab 300 mg IV every 4 weeks
Number of subjects: 43
Study 35134970 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 34433598 — intervention group
Group type: EXPERIMENTAL
Intervention: VR (eHBB+digital guide)
Number of subjects: 274
Study 34433598 — intervention group
Group type: EXPERIMENTAL
Intervention: Video (video+digital guide)
Number of subjects: 274
Study 34433598 — intervention group
Group type: COMPARATOR
Intervention: Control (digital guide only)
Number of subjects: 274
Study 33472510 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavior Therapy (gCBT)
Number of subjects: 48
Study 33472510 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 48
Study 34022937 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose tranexamic acid
Number of subjects: 20127
Study 34022937 — intervention group
Group type: COMPARATOR
Intervention: Identical placebo
Number of subjects: 20127
Study 36279220 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard CBT (nine sessions prior to exposure initiation)
Number of subjects: 148
Study 36279220 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted CBT (exposure following the fifth session)
Number of subjects: 148
Study 36279220 — intervention group
Group type: COMPARATOR
Intervention: Cognitive skills introduction
Number of subjects: 148
Study 34333473 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D VR models
Number of subjects: 10
Study 34333473 — intervention group
Group type: COMPARATOR
Intervention: 2D images
Number of subjects: 10
Study 32502550 — intervention group
Group type: EXPERIMENTAL
Intervention: Linked-color imaging (LCI)
Number of subjects: 649
Study 32502550 — intervention group
Group type: COMPARATOR
Intervention: White-light imaging (WLI)
Number of subjects: 649
Study 34579066 — intervention group
Group type: EXPERIMENTAL
Intervention: Test product (prolonged-release AA mixture formulated with Physiomimic Technology™)
Number of subjects: 30
Study 34579066 — intervention group
Group type: COMPARATOR
Intervention: Reference product (free AA mixture)
Number of subjects: 30
Study 32097999 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training (12 weeks)
Number of subjects: 45
Study 32097999 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 45
Study 36201813 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered treatment for anxiety and depression over 8 weeks
Number of subjects: 576
Study 33762655 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume‐oriented incentive spirometry (VIS)
Number of subjects: 72
Study 33762655 — intervention group
Group type: COMPARATOR
Intervention: Flow‐oriented incentive spirometry (FIS)
Number of subjects: 72
Study 33762655 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic breathing exercise (DBE)
Number of subjects: 72
Study 32778491 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT)
Number of subjects: 377
Study 32778491 — intervention group
Group type: COMPARATOR
Intervention: Bypass surgery (BS)
Number of subjects: 377
Study 33676429 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended AUD treatment (face-to-face contact with a therapist combined with internet modules)
Number of subjects: 1800
Study 33676429 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face treatment only (treatment as usual, TAU)
Number of subjects: 1800
Study 33676429 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended AUD treatment
Number of subjects: 1800
Study 33676429 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face treatment only (TAU)
Number of subjects: 1800
Study 35287694 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 hours of passive subdural drainage
Number of subjects: 0
Study 35287694 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 hours of passive subdural drainage
Number of subjects: 0
Study 35287694 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 hours of passive subdural drainage
Number of subjects: 0
Study 35287694 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 questionnaire
Number of subjects: 0
Study 35287694 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of hospital stay
Number of subjects: 0
Study 35287694 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain-related complications
Number of subjects: 0
Study 35287694 — intervention group
Group type: EXPERIMENTAL
Intervention: Complications related to immobilization and mortality
Number of subjects: 0
Study 34349372 — intervention group
Group type: COMPARATOR
Intervention: Combined spinal-epidural (CSE)
Number of subjects: 0
Study 34349372 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural (EPL)
Number of subjects: 0
Study 34349372 — intervention group
Group type: EXPERIMENTAL
Intervention: Dural puncture epidural (DPE)
Number of subjects: 0
Study 34349372 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural (EPL) and Dural puncture epidural (DPE)
Number of subjects: 0
Study 34801738 — intervention group
Group type: EXPERIMENTAL
Intervention: Umifenovir (800 mg BID, maximum 14 days)
Number of subjects: 132
Study 34801738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 32170359 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-developed collateralization (Rentrop grade 2 or 3)
Number of subjects: 95
Study 32170359 — intervention group
Group type: COMPARATOR
Intervention: Poor collateralization (Rentrop grade 0 or 1)
Number of subjects: 95
Study 36426809 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (group M)
Number of subjects: 140
Study 36426809 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (group O)
Number of subjects: 140
Study 34442453 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 108
Study 34442453 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Number of subjects: 108
Study 34442453 — intervention group
Group type: COMPARATOR
Intervention: Placebo kinesio tape
Number of subjects: 108
Study 34442453 — intervention group
Group type: COMPARATOR
Intervention: Placebo auricular acupressure
Number of subjects: 108
Study 34442453 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108
Study 36200632 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-consumer advertising for heart disease medications (treatment 1)
Number of subjects: 2874
Study 36200632 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-consumer advertising for heart disease medications with price disclosure (treatment 2)
Number of subjects: 2874
Study 36200632 — intervention group
Group type: COMPARATOR
Intervention: Nonpharmaceutical advertising (control group)
Number of subjects: 2874
Study 34983456 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted INTERGROWTH-21st Project Neurodevelopment Assessment (INTER-NDA)
Number of subjects: 37
Study 34983456 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-specialist child development assessors
Number of subjects: 37
Study 35368362 — intervention group
Group type: EXPERIMENTAL
Intervention: AVF ligation
Number of subjects: 27
Study 35368362 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 35380934 — intervention group
Group type: EXPERIMENTAL
Intervention: Care seeking for mental or sexual and reproductive health
Number of subjects: 2084
Study 35380934 — intervention group
Group type: EXPERIMENTAL
Intervention: General care seeking reasons
Number of subjects: 2084
Study 35380934 — intervention group
Group type: COMPARATOR
Intervention: Care seeking specifically for SV
Number of subjects: 2084
Study 34121063 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (40 IU)
Number of subjects: 73
Study 34121063 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 73
Study 32933927 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week pulmonary rehabilitation programme
Number of subjects: 72
Study 32933927 — intervention group
Group type: COMPARATOR
Intervention: 12-week pulmonary rehabilitation programme
Number of subjects: 72
Study 34147912 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (100 mcg twice daily) with olfactory training for 4 weeks
Number of subjects: 80
Study 34147912 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (0.9%) with olfactory training for 4 weeks
Number of subjects: 80
Study 34147912 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray with olfactory training
Number of subjects: 80